Skip to content

Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation

Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01319708
Enrollment
50
Registered
2011-03-22
Start date
2011-03-31
Completion date
2015-09-30
Last updated
2015-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

ovarian stimulation, climiphene citrate, Gonadotropin-Releasing Hormone agonists/antagonists, Follicle Stimulating Hormone

Brief summary

The investigators will examine the balance between IVF success in terms of outcome parameters, using a mild ovarian stimulation protocol, opposing it to the conventional stimulation regimens in poor responders undergoing IVF.

Interventions

PROCEDUREmild ovarian stimulation

100-150 mg of clomiphene citrate from day 2 till day 6 of the cycle and 150 mg of gonadotrophins as soon as 1 follicle is more than 14mm together with 1 fixed dose of GnRH antagonist until egg recovery

300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses with GnRH agonist long protocol

Sponsors

National and Kapodistrian University of Athens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* poor responders (age\>40, previous POR, abnormal OR test) * indication for IVF * regular cycling patients * BMI 19-35

Exclusion criteria

* contraindication for clomiphene citrate use or to GnRH agonists antagonists * BMI \> 35

Design outcomes

Primary

MeasureTime frame
number of oocytes (COCs)at oocyte recovery

Secondary

MeasureTime frameDescription
clinical pregnancy rate6 weeksPresence of fetal heart at transvaginal ultrasound at 6 weeks of gestation or 6 weeks after starting the intervention
live birthmore than 20 weeks
Number/rate of participants whom the IVF cycle was cancelledAfter the 1st week of ovarian stimulation, no oocytes at OR
stimulation characteristicsfrom start of stimulation until embryo transfertotal dose of gonadotropins administered,
cancellation ratefrom start of stimulation until ETwhen premature ovulation was evident by the loss of follicle(s) prior to oocyte recovery, and in cases where there were no oocytes retrieved or no embryos produced for transfer and in failed fertilization
miscarriagepregnancy loss before 20 weeks of gestation, after a positive pregnancy test

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026